Early Serum Calprotectin (S100A8/A9) Predicts Delayed Cerebral Ischemia and Outcomes after Aneurysmal Subarachnoid Hemorrhage

Aneurysmal subarachnoid hemorrhage (aSAH) not only has a high early mortality, but also leads to serious long-term neurological dysfunction. Looking for biomarkers that can predict the prognosis of patients will contribute to the decision-making of early treatment. Current clinical scores, such as Glasgow Coma Scale (GCS) score, Hunt and Hess scale, and Fisher grade, can determine the clinical neurological status of patients. However, because of sedation or disturbance of consciousness, the neurological status of patient is sometimes difficult to assess.
Source: Journal of Stroke and Cerebrovascular Diseases - Category: Neurology Authors: Source Type: research